Patent ID: 9687509
Date: 2017-06-27
CPC Classifications: A61K,A61L,A61P,Y10T

Claim:
1. A formulation comprising at least one silver oxide including a silver(II) oxide, said at least one silver oxide having an average particle size (D 50 ) within a range of from above 0.8 micrometers to below 8 micrometers, said silver(II) oxide having an irregular macrocrystal structure, said irregular macrocrystal structure characterized by a diffraction peak in a {111} diffraction plane, said diffraction peak having at least one of the following structural properties: (i) a measured full width half maximum (FWHM) of at least 0.30 degrees of 2θ and not more than 0.466 degrees of 2θ; and (ii) a net full width half maximum (net FWHM) of at least 0.20 degrees of 2θ and not more than 0.366 degrees of 2θ; the formulation being a topical formulation suitable for application to skin tissue, wherein said silver oxide predominantly includes said silver(II) oxide.